Data coverage, completeness and provenance for BLS PHARMACEUTICALS LIMITED in the Stock Market API — Consumer Staples · Biotechnology.
Source date: 2026-10-30T05:10:11. Source: yfinance. Collection time is shown separately and does not establish a trade date.
| Date | Close | Currency | Source | Adjustment basis |
|---|---|---|---|---|
| 2026-10-30 | 1.0250 | AUD | yfinance | Split- and dividend-adjusted close |
| 2026-10-29 | 1.0500 | AUD | yfinance | Split- and dividend-adjusted close |
| 2026-10-28 | 1.0100 | AUD | yfinance | Split- and dividend-adjusted close |
| 2026-10-27 | 1.0000 | AUD | yfinance | Split- and dividend-adjusted close |
| 2026-10-26 | 0.9500 | AUD | yfinance | Split- and dividend-adjusted close |
GET /api/v1/companies/BLS/prices · Price parameters and adjustment semantics
BLS Pharmaceuticals Limited, together with its subsidiaries, manufactures and distributes therapeutic goods, and health and wellness products in Australia, the United States, the United Kingdom, Czech Republic, and Japan. The company offers medical cannabis, MDMA, psilocybin, prescription medicines, probiotics, NADs, and consumer health products under the Dr Watson and PCC brands. It also provides pharmaceutical manufacturing, wholesale, distribution, import, export, and contract drug manufacturing services for investigational and psychotropic medicines. The company caters to licensed clinics, pharmacies, wholesale distributors, cultivators, active pharmaceutical ingredient manufacturers, and pharmaceutical brand sponsors. The company was formerly known as Bioxyne Limited and changed its name to BLS Pharmaceuticals Limited in June 2026. BLS Pharmaceuticals Limited was incorporated in 1998 and is headquartered in Sydney, Australia.
Website: https://blspharma.com · Profile fields populated: 60%
Share of stored fields populated in the anchor reporting period (FY2026), primary source yfinance. Full per-field breakdown: GET /api/v1/companies/BLS/financials.
Stored values for the most recent fiscal-year periods, with per-period field counts and the primary source each period came from. Values are shown at reported scale without interpretation.
| Period | Period end | Revenue | Net income | Total assets | Total equity | Fields populated | Source |
|---|---|---|---|---|---|---|---|
| FY2026 (AUD) | 2026-06-30 | 30 | yfinance | ||||
| FY2024 (AUD) | 2024-06-30 | 29 | yfinance | ||||
| FY2023 (AUD) | 2023-06-30 | 27 | yfinance | ||||
| FY2022 (AUD) | 2022-06-30 | 24 | yfinance |
The endpoints below describe available datasets for this listing. Missing fields remain unknown. Free API keys — no card required.
Name, sector, industry, HQ, employees, market cap, source-tagged.
GET /api/v1/companies/BLS
Multi-year statements with per-field source tags and completeness.
GET /api/v1/companies/BLS/financials
P/E, P/B, ROE, ROA, margins, EPS, debt/equity — formulas documented.
GET /api/v1/companies/BLS/metrics/summary
Report PDFs with LLM-ready markdown conversions where available.
GET /api/v1/companies/BLS/filings
Dated press releases and announcements with source links.
GET /api/v1/companies/BLS/news
Create a free key, then:
curl -H "X-API-Key: KEY" https://stockmarketapi.ai/api/v1/companies/BLS
Free tier — instant API key. Built for AI agents.